| Title |
Mono- and combinational drug therapies for global viral pandemic preparedness / |
| Authors |
Ianevski, Aleksandr ; Yao, Rouan ; Simonsen, Ronja M ; Myhre, Vegard ; Ravlo, Erlend ; Kaynova, Gerda D ; Zusinaite, Eva ; White, Judith M ; Polyak, Stephen J ; Oksenych, Valentyn ; Windisch, Marc P ; Pan, Qiuwei ; Lastauskienė, Eglė ; Vitkauskienė, Astra ; Matukevičius, Algimantas ; Tenson, Tanel ; Bjørås, Magnar ; Kainov, Denis E |
| DOI |
10.1016/j.isci.2022.104112 |
| Full Text |
|
| Is Part of |
iScience.. Cambridge, MA : Cell Press. 2022, vol. 25, no. 4, p. 6716-6729.. eISSN 2589-0042 |
| Keywords [eng] |
chemistry ; pharmaceutical preparation ; pharmaceutical science ; pharmacology |
| Abstract [eng] |
Broadly effective antiviral therapies must be developed to be ready for clinical trials, which should begin soon after the emergence of new life-threatening viruses. Here, we pave the way towards this goal by reviewing conserved druggable virus-host interactions, mechanisms of action, immunomodulatory properties of available broad-spectrum antivirals (BSAs), routes of BSA delivery, and interactions of BSAs with other antivirals. Based on the review, we concluded that the range of indications of BSAs can be expanded, and new pan- and cross-viral mono- and combinational therapies can be developed. We have also developed a new scoring algorithm that can help identify the most promising few of the thousands of potential BSAs and BSA-containing drug cocktails (BCCs) to prioritize their development during the critical period between the identification of a new virus and the development of virus-specific vaccines, drugs, and therapeutic antibodies. |
| Published |
Cambridge, MA : Cell Press |
| Type |
Journal article |
| Language |
English |
| Publication date |
2022 |
| CC license |
|
